Bb Biotech as of June 30, 2013
Portfolio Holdings for Bb Biotech
Bb Biotech holds 23 positions in its portfolio as reported in the June 2013 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Celgene Corporation | 18.1 | $252M | 2.2M | 116.98 | |
| ISIS Pharmaceuticals | 15.0 | $209M | 7.8M | 26.87 | |
| Gilead Sciences (GILD) | 13.7 | $190M | 3.7M | 51.27 | |
| Incyte Corporation (INCY) | 8.5 | $118M | 5.4M | 22.00 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 8.1 | $112M | 1.4M | 80.06 | |
| Alexion Pharmaceuticals | 5.2 | $72M | 778k | 92.24 | |
| Medivation | 5.1 | $71M | 1.4M | 49.20 | |
| Ariad Pharmaceuticals | 3.9 | $55M | 3.1M | 17.49 | |
| ImmunoGen | 3.9 | $54M | 3.3M | 16.59 | |
| Onyx Pharmaceuticals | 3.4 | $47M | 547k | 86.82 | |
| Halozyme Therapeutics (HALO) | 3.2 | $45M | 5.6M | 7.95 | |
| Theravance | 2.5 | $34M | 888k | 38.53 | |
| Endocyte | 2.2 | $31M | 2.3M | 13.13 | |
| Optimer Pharmaceuticals | 1.5 | $21M | 1.4M | 14.47 | |
| Infinity Pharmaceuticals (INFIQ) | 1.3 | $18M | 1.1M | 16.19 | |
| Alnylam Pharmaceuticals (ALNY) | 1.0 | $14M | 455k | 31.00 | |
| Achillion Pharmaceuticals | 1.0 | $14M | 1.7M | 8.18 | |
| BioMarin Pharmaceutical (BMRN) | 0.7 | $9.9M | 178k | 55.74 | |
| Medicines Company | 0.7 | $9.3M | 303k | 30.76 | |
| Idenix Pharmaceuticals | 0.3 | $4.5M | 1.3M | 3.61 | |
| Dendreon Corporation | 0.3 | $4.2M | 1.0M | 4.12 | |
| Trius Therapeutics | 0.2 | $2.3M | 280k | 8.10 | |
| Synageva Biopharma | 0.2 | $2.2M | 54k | 41.98 |
